Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2021-10-25 00:00:00 ET · period of report 2021-10-20 · accession 0001228924-21-000074 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-25 | 2021-10-20 | MLAB | Sakys John | CFO | S - Sale+OE | $309.86 | -2,000 | 7,514 | -21% | -$619.7K |
| D | 2021-10-25 | 2021-10-20 | MLAB | Sakys John | CFO | M - OptEx | $97.78 | +2,000 | 9,514 | +27% | +$195.6K |
| D | 2021-10-25 | 2021-10-20 | MLAB | Sakys John | CFO | X - OptEx | $0.00 | -2,000 | 31.0K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-20 | S | D | 2,000 | $309.86 | 7,514 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on March 1, 2021 |
| 2 | Common | Common Stock | 2021-10-20 | M | A | 2,000 | $97.78 | 9,514 | D | — | — | |
| 3 | Derivative | Non Qualified Stock Option | 2021-10-20 | X | D | 2,000 | $0.00 | 31,029 | D | $97.78 · 2017-04-01 to 2022-04-01 | 2,000 Common Stock | (F1) 1/5 exercisable on each anniversary date of the 04-01-2016 grant date |